Short Neuropsychological Assessment in Schizophrenic Patients
Author(s) -
Theofilidis Antonis
Publication year - 2021
Language(s) - English
DOI - 10.47363/jpsrr/2020(3)118
Subject(s) - montreal cognitive assessment , schizophrenia (object oriented programming) , neuropsychology , cognition , neuropsychological test , psychology , executive functions , neuropsychological assessment , neuropsychological testing , cognitive assessment system , clinical psychology , test (biology) , psychiatry , cognitive impairment , audiology , medicine , paleontology , biology
Patients with schizophrenia show deficits in executive functions, resembling patterns also found in frontal lesions. The advent of these findings shows the need for appropriate short neuropsychological screening tests in order to assess cognitive function in schizophrenia. Method: We gathered data from a patient group with schizophrenia, and from a control group. We administered 3 short, fast screening tests: MOCA (Montreal Cognitive Assessment), MMSE (Mini Mental State Exam) and FAB (Frontal Assessment Battery). Results: All 3 test were found to be highly correlated with each other, with MOCA being a predictor factor for FAB scores. In measuring the 3 tests’ sensitivity to schizophrenia associated cognitive impairments, we found that FAB was the most sensitive among the three. Conclusions: Our goal was to examine the utility of the FAB test when screening for cognitive deficits in Greek patients with schizophrenia. We found that FAB can be a valuable tool in neuropsychological assessment, but given the varied nature of patients with schizophrenia cognitive profile, it should be accompanied with an extensive battery of tests.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom